Please provide your email address to receive an email when new articles are posted on . The FDA approved paltusotine for first-line treatment of patients with acromegaly who did not respond to or ...
Acromegaly is a rare but serious hormonal disorder caused by excess growth hormone, usually due to a benign tumour in the pituitary gland. It typically develops in adulthood and leads to noticeable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results